Table 5.
Associations of COVID-19 severity with risk of diabetes incidence after discharge.
| Critical Ill Patients | p Value | p for Interaction | ||
|---|---|---|---|---|
| No | Yes | |||
| Total patients | ||||
| Incidents/patients (%) | 9/153 (5.9%) | 10/68 (14.7%) | ||
| OR (95% CI) | Ref. | 2.90 (1.07, 7.88) | 0.04 | |
| Sex | 0.14 | |||
| Male | ||||
| Incidents/patients (%) | 4/65 (6.2%) | 8/37 (21.6%) | ||
| OR (95% CI) | Ref. | 5.70 (1.46, 22.15) | 0.01 | |
| Female | ||||
| Incidents/patients (%) | 5/88 (5.7%) | 2/31 (6.5%) | ||
| OR (95% CI) | Ref. | 0.84 (0.12, 6.00) | 0.86 | |
Notes: Models adjusted for age, sex, smoking, drinking, hypertension, and other chronic comorbidities, including cardiovascular disease, cerebrovascular disease, chronic liver disease, chronic kidney disease, cancer, chronic pulmonary disease, and interleukin-8. The subgroup analysis adjusted the same variables except for the stratification variable.